C12N 2770/32322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/32322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 23 US grants and 40 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 40
- Assignees
- 40
- Inventors
- 136
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 2 | 0 |
| 2008 | 0 | 2 |
| 2009 | 1 | 1 |
| 2010 | 0 | 4 |
| 2011 | 0 | 1 |
| 2012 | 3 | 5 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 2 | 2 |
| 2020 | 2 | 4 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 2 | 2 |
| 2024 | 3 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adapted enterovirus D68 that propagates to high titer in vero cells6 May 2025US 12,290,555 B2Bharat Biotech International Limited
- Enterovirus multi-antigen epitope fusion protein, gene, vaccine, and preparation method thereof13 Aug 2024US 12,060,389 B1Institute of Medical Biology, Chinese Academy of Medical Sciences
- Recombinant nucleic acid molecule based on point mutation of translation initiation element and use thereof in preparation of circular RNA6 Aug 2024US 12,054,722 B2Purecodon (Hong Kong) Biopharma Ltd.
- Genetically engineered coxsackievirus, and pharmaceutical composition16 Jul 2024US 12,037,608 B2N.P.T. S.R.L.
- Echovirus for treatment of tumors25 Jul 2023US 11,707,496 B2Xiamen University
- Chimeric invasin system5 Mar 2026US 2026/0062730 A1SiVEC Biotechnologies LLC
- Coxsackievirus B Compositions and Methods Of Use Thereof20 Nov 2025US 2025/0352634 A1Vactech Oy
- Using infectious nucleic acid to treat cancer7 Aug 2025US 2025/0249053 A1Mayo Foundation for Medical Education and Research
- Compositions and methods for enhanced antigen binding proteins15 Aug 2024US 2024/0269256 A1HDT Bio Corp.
- Coxsackievirus 83 Vaccine8 Aug 2024US 2024/0261386 A1King Faisal University
Most cited
By later US patents
- Screening method for chronic immune dysfunction syndrome35US 5,426,028 ARush-Presbyterian-St. Luke's Medical Center · 1995
- Screening kit and method for diagnosing chronic immune dysfunction syndrome34US 5,538,856 AThe Regents of the University of California · 1996
- Peptides useful in vaccination against enteroviruses11US 4,857,634 ANational Research Development Corporation · 1989
- Autocatalytic cleavage site and use thereof in a protein expression vector6US 5,912,167 AWisconsin Alumni Research Foundation · 1999
- Swine vesicular disease virus and mutant strains and preparation process and use thereof4US 6,200,576 B1Development Center for Biotechnology · 2001